Gevo (NASDAQ: GEVO) and Amyris (NASDAQ:AMRS) are both small-cap oils/energy companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability.
Earnings & Valuation
This table compares Gevo and Amyris’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Gevo||$27.54 million||0.27||-$24.63 million||($1.61)||-0.19|
|Amyris||$143.45 million||1.87||-$72.32 million||($3.05)||-1.77|
Gevo has higher earnings, but lower revenue than Amyris. Amyris is trading at a lower price-to-earnings ratio than Gevo, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent ratings and target prices for Gevo and Amyris, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Gevo presently has a consensus target price of $12.00, suggesting a potential upside of 3,757.28%. Amyris has a consensus target price of $9.67, suggesting a potential upside of 78.68%. Given Gevo’s higher probable upside, analysts plainly believe Gevo is more favorable than Amyris.
This table compares Gevo and Amyris’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Gevo has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500. Comparatively, Amyris has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500.
Insider & Institutional Ownership
7.0% of Gevo shares are held by institutional investors. Comparatively, 24.0% of Amyris shares are held by institutional investors. 0.1% of Gevo shares are held by insiders. Comparatively, 21.8% of Amyris shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks in the United States. It operates through two segments, Gevo, Inc. and Gevo Development/Agri-Energy. The company engages in the research and development, and production of isobutanol; development of its proprietary biocatalysts; production and sale of biojet fuel; and retrofit process of chemicals and biofuels. It is also involved in the production of ethanol, isobutanol, and related products. In addition, the company produces and separates its renewable isobutanol through the Gevo Integrated Fermentation Technology platform. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and lubricants for industrial markets; Biofene ingredients for nutraceuticals and vitamins market; and renewable fuels for transportation fuels markets. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.